| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |